Karalex Pharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Karalex Pharma General Information
Description
Manufacturer of pharmaceutical products. The company is engaged in the production and distribution of generic pharmaceuticals products focused exclusively on the United States healthcare market.
Contact Information
Website
www.karalexpharma.comCorporate Office
- 100 Overlook Center
- 2nd Floor
- Princeton, NJ 08540
- United States
Corporate Office
- 100 Overlook Center
- 2nd Floor
- Princeton, NJ 08540
- United States
Karalex Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Karalex Pharma Signals
Karalex Pharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Karalex Pharma FAQs
-
When was Karalex Pharma founded?
Karalex Pharma was founded in 2007.
-
Who is the founder of Karalex Pharma?
Nick DiMaio and Julie Trendowicz are the founders of Karalex Pharma.
-
Where is Karalex Pharma headquartered?
Karalex Pharma is headquartered in Princeton, NJ.
-
What is the size of Karalex Pharma?
Karalex Pharma has 2 total employees.
-
What industry is Karalex Pharma in?
Karalex Pharma’s primary industry is Pharmaceuticals.
-
Is Karalex Pharma a private or public company?
Karalex Pharma is a Private company.
-
What is Karalex Pharma’s current revenue?
The current revenue for Karalex Pharma is 000000.
-
Who are Karalex Pharma’s investors?
Eagle Pharmaceuticals has invested in Karalex Pharma.
-
When was Karalex Pharma acquired?
Karalex Pharma was acquired on 02-Jul-2010.
-
Who acquired Karalex Pharma?
Karalex Pharma was acquired by Orchid Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »